NL8902657A - Cyclosporine bevattende ophthalmische preparaten. - Google Patents

Cyclosporine bevattende ophthalmische preparaten. Download PDF

Info

Publication number
NL8902657A
NL8902657A NL8902657A NL8902657A NL8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A
Authority
NL
Netherlands
Prior art keywords
preparation
eye
present
amount
component
Prior art date
Application number
NL8902657A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8902657A publication Critical patent/NL8902657A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NL8902657A 1988-10-26 1989-10-26 Cyclosporine bevattende ophthalmische preparaten. NL8902657A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US26286688 1988-10-26

Publications (1)

Publication Number Publication Date
NL8902657A true NL8902657A (nl) 1990-05-16

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8902657A NL8902657A (nl) 1988-10-26 1989-10-26 Cyclosporine bevattende ophthalmische preparaten.

Country Status (23)

Country Link
JP (1) JPH02164830A (OSRAM)
KR (1) KR900005973A (OSRAM)
AU (1) AU626928B2 (OSRAM)
BE (1) BE1003578A4 (OSRAM)
CA (1) CA2001502A1 (OSRAM)
CH (1) CH679210A5 (OSRAM)
DE (1) DE3935517A1 (OSRAM)
DK (1) DK531289A (OSRAM)
ES (1) ES2020032A6 (OSRAM)
FI (1) FI895064A7 (OSRAM)
FR (1) FR2638089A1 (OSRAM)
GB (1) GB2224205B (OSRAM)
GR (1) GR1000611B (OSRAM)
HU (1) HU203046B (OSRAM)
IL (1) IL92120A (OSRAM)
LU (1) LU87613A1 (OSRAM)
MY (1) MY106271A (OSRAM)
NL (1) NL8902657A (OSRAM)
NO (1) NO894266L (OSRAM)
NZ (1) NZ231131A (OSRAM)
PT (1) PT92120B (OSRAM)
SE (1) SE8903583L (OSRAM)
ZA (1) ZA898140B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
JP2000516256A (ja) 1997-01-30 2000-12-05 ノバルティス アクチエンゲゼルシャフト サイクロスポリンａを含む無油医薬組成物
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
AU2010256652B2 (en) * 2009-06-05 2015-11-26 Allergan, Inc. Artificial tears and therapeutic uses
RU2697844C9 (ru) 2014-11-25 2019-10-01 Аллерган, Инк. Стабилизированные композиции для офтальмологического применения, содержащие омега-3-кислоты
CA3149046A1 (en) * 2019-09-06 2021-03-11 Jorg Haisser Ophthalmic composition for the treatment of uveitis
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
FI895064A0 (fi) 1989-10-25
FR2638089A1 (fr) 1990-04-27
MY106271A (en) 1995-04-29
CH679210A5 (OSRAM) 1992-01-15
JPH02164830A (ja) 1990-06-25
DK531289D0 (da) 1989-10-25
CA2001502A1 (en) 1990-04-26
ZA898140B (en) 1991-06-26
SE8903583L (sv) 1990-04-27
DK531289A (da) 1990-04-27
HUT52394A (en) 1990-07-28
AU626928B2 (en) 1992-08-13
BE1003578A4 (fr) 1992-04-28
SE8903583D0 (sv) 1989-10-26
NO894266L (no) 1990-04-27
HU203046B (en) 1991-05-28
GB2224205B (en) 1992-04-15
AU4371589A (en) 1990-05-03
GR890100690A (en) 1990-11-29
NZ231131A (en) 1992-06-25
PT92120A (pt) 1990-04-30
KR900005973A (ko) 1990-05-07
LU87613A1 (fr) 1991-05-07
IL92120A (en) 1994-02-27
DE3935517A1 (de) 1990-05-03
GR1000611B (el) 1992-08-31
GB2224205A (en) 1990-05-02
PT92120B (pt) 1995-06-30
NO894266D0 (no) 1989-10-26
IL92120A0 (en) 1990-07-12
ES2020032A6 (es) 1991-07-16
FI895064A7 (fi) 1990-04-27
HU895444D0 (en) 1990-01-28
GB8924040D0 (en) 1989-12-13

Similar Documents

Publication Publication Date Title
NL8902657A (nl) Cyclosporine bevattende ophthalmische preparaten.
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
Van Ooteghem Formulation of ophthalmic solutions and suspensions. Problems and advantages
EP2968139B1 (en) Microemulsion topical delivery platform
RU2747455C2 (ru) Циклоспорин-содержащие лекарственные формы для наружного применения и их применения
JP2006176499A (ja) 眼疾患治療剤
JP2004346085A (ja) シクロスポリン含有眼科用組成物
JP2020535156A (ja) 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
HRP20000258A2 (en) Topical ophthalmic preparations containing immunosuppressive agents
JP2022546980A (ja) ブドウ膜炎の治療のための眼科用組成物
Berdy et al. Allergic conjunctivitis: a survey of new antihistamines
US20100174000A1 (en) Carrier in the form of oil-in-water emulsion notably intended for ophthalmic or dermocosmetic use
RU2134107C1 (ru) Препарат "гистохром" для лечения воспалительных заболеваний сетчатки и роговицы глаз
McCLANAHAN et al. Ocular manifestations of chronic phenothiazine derivative administration
JP2632010B2 (ja) シクロスポリン製剤
Beasley et al. Carbachol in cataract surgery
Grehn et al. Thymoxamine: a miotic for intraocular use
Alani et al. The ophthalmic rod—a new drug-delivery system II
Blanksma Concentration of timolol in aqueous humour
WO2025163485A1 (en) Ophthalmic pharmaceutical composition
Schwartz APPENDIX B BIBLIOGRAPHY OF CORTICOSTEROIDS AND THE EYE
ZALTA et al. The effect of nitroglycerin ointment on the external ocular structures of rabbits
HK40044057A (en) Pharmaceutical compositions comprising nebivolol
Khodakiya Formulation Design and Optimization of topical Microemulsion in Situ Gelling System: Drug Delivery to Posterior Segment of the Eye
Kralinger et al. Acetylsalicylic acid–silicone oil suspension for proliferative vitreoretinopathie: First results of Austrian clinical multicentre study

Legal Events

Date Code Title Description
BV The patent application has lapsed